• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟碳改性壳聚糖实现黑色素瘤透皮免疫治疗。

Fluorocarbon Modified Chitosan to Enable Transdermal Immunotherapy for Melanoma Treatment.

机构信息

Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, Jiangsu, 215123, China.

Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, 199 Ren'ai Rd, Suzhou, Jiangsu, 215123, China.

出版信息

Small. 2023 Nov;19(46):e2303634. doi: 10.1002/smll.202303634. Epub 2023 Jul 19.

DOI:10.1002/smll.202303634
PMID:37467294
Abstract

Despite the rapid development of the immune checkpoint blockade (ICB) in melanoma treatment, the immunosuppressive tumor microenvironment (TME) still hinders the efficacy of immunotherapy. Recently, using agonists to modulate the TME have presented promising clinical responses in combination with ICB therapies. However, local intratumoral injection as the commonly used administration route for immune agonists would lead to low patient compliance. Herein, it is demonstrated that fluorocarbon modified chitosan (FCS) can self-assemble with immune adjuvant polyriboinosinic:polyribocytidylic acid (poly(I:C)), forming nanoparticles that can penetrate through cutaneous barriers to enable transdermal delivery. FCS/poly(I:C) can efficiently activate various types of cells presented on the transdermal route (through the skin into the TME), leading to IRF3-mediated IFN-β induction in the activated cells for tumor repression. Furthermore, transdermal FCS/poly(I:C) treatment can significantly magnify the efficacy of the programmed cell death protein 1 (PD-1) blockade in melanoma treatment through activating the immunosuppressive TME. This study approach offered an attractive transdermal approach in combined with ICB therapy for combined immunotherapy, particularly suitable for melanoma treatment.

摘要

尽管免疫检查点阻断(ICB)在黑色素瘤治疗方面发展迅速,但免疫抑制性肿瘤微环境(TME)仍然阻碍了免疫疗法的疗效。最近,使用激动剂来调节 TME 与 ICB 治疗联合已显示出有希望的临床反应。然而,免疫激动剂的常用给药途径——局部瘤内注射会导致患者顺应性低。本文证明,氟碳改性壳聚糖(FCS)可以与免疫佐剂聚肌苷酸:聚胞苷酸(poly(I:C)) 自组装,形成纳米颗粒,可穿透皮肤屏障实现经皮给药。FCS/poly(I:C) 可以有效地激活经皮途径(通过皮肤进入 TME)上存在的各种类型的细胞,导致激活细胞中的干扰素调节因子 3 (IRF3) 介导的 IFN-β诱导,从而抑制肿瘤。此外,经皮 FCS/poly(I:C) 治疗可以通过激活免疫抑制性 TME 显著提高程序性细胞死亡蛋白 1 (PD-1) 阻断在黑色素瘤治疗中的疗效。该研究方法为联合 ICB 治疗的联合免疫疗法提供了一种有吸引力的经皮方法,特别适用于黑色素瘤的治疗。

相似文献

1
Fluorocarbon Modified Chitosan to Enable Transdermal Immunotherapy for Melanoma Treatment.氟碳改性壳聚糖实现黑色素瘤透皮免疫治疗。
Small. 2023 Nov;19(46):e2303634. doi: 10.1002/smll.202303634. Epub 2023 Jul 19.
2
Non-invasive transdermal delivery of biomacromolecules with fluorocarbon-modified chitosan for melanoma immunotherapy and viral vaccines.用于黑色素瘤免疫治疗和病毒疫苗的含氟碳修饰壳聚糖的生物大分子无创透皮递送
Nat Commun. 2024 Jan 27;15(1):820. doi: 10.1038/s41467-024-45158-6.
3
Noninvasive Transdermal Delivery of STING Agonists Reshapes the Immune Microenvironment of Melanoma and Potentiates Checkpoint Blockade Therapy Efficacy.STING激动剂的非侵入性透皮递送重塑黑色素瘤免疫微环境并增强免疫检查点阻断疗法疗效。
ACS Appl Bio Mater. 2025 Apr 21;8(4):3156-3166. doi: 10.1021/acsabm.4c02004. Epub 2025 Apr 7.
4
Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.使用 TLR2/3 激动剂 L-pampo 进行肿瘤内免疫治疗可诱导强烈的抗肿瘤免疫反应,并增强免疫检查点阻断。
J Immunother Cancer. 2022 Jun;10(6). doi: 10.1136/jitc-2022-004799.
5
Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.局部和靶向递送免疫检查点阻断治疗药物。
Acc Chem Res. 2020 Nov 17;53(11):2521-2533. doi: 10.1021/acs.accounts.0c00339. Epub 2020 Oct 19.
6
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.黑色素瘤研究的未来展望:“黑色素瘤桥梁”会议报告。那不勒斯,2015年12月1日至4日
J Transl Med. 2016 Nov 15;14(1):313. doi: 10.1186/s12967-016-1070-y.
7
T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.T 细胞介导的他达拉非靶向递药调节免疫抑制和多胺代谢,以克服肝癌的免疫检查点阻断耐药性。
J Immunother Cancer. 2023 Feb;11(2). doi: 10.1136/jitc-2022-006493.
8
IL-32γ potentiates tumor immunity in melanoma.IL-32γ 增强黑色素瘤中的肿瘤免疫。
JCI Insight. 2020 Sep 17;5(18):138772. doi: 10.1172/jci.insight.138772.
9
Targeting the atypical chemokine receptor 2 () improves the benefit of anti-PD-1 immunotherapy in melanoma mouse model.靶向非典型趋化因子受体2()可提高抗PD-1免疫疗法在黑色素瘤小鼠模型中的疗效。
Oncoimmunology. 2025 Dec;14(1):2494426. doi: 10.1080/2162402X.2025.2494426. Epub 2025 Apr 18.
10
Tumor Microenvironment-Activable Manganese-Boosted Catalytic Immunotherapy Combined with PD-1 Checkpoint Blockade.肿瘤微环境激活的锰增强催化免疫疗法联合PD-1检查点阻断疗法
ACS Nano. 2022 Dec 27;16(12):20400-20418. doi: 10.1021/acsnano.2c06646. Epub 2022 Nov 28.

引用本文的文献

1
Opportunities, obstacles and challenges of nano-immunotherapy in melanoma.纳米免疫疗法在黑色素瘤治疗中的机遇、障碍与挑战
Front Immunol. 2025 Aug 8;16:1611423. doi: 10.3389/fimmu.2025.1611423. eCollection 2025.
2
Enhanced Cellular Immunity for Hepatitis B Virus Vaccine: A Novel Polyinosinic-Polycytidylic Acid-Incorporated Adjuvant Leveraging Cytoplasmic Retinoic Acid-Inducible Gene-Like Receptor Activation and Increased Antigen Uptake.乙型肝炎病毒疫苗的增强细胞免疫:一种新型的含聚肌苷酸-聚胞苷酸佐剂,利用细胞质视黄酸诱导基因样受体激活并增加抗原摄取。
Biomater Res. 2024 Oct 28;28:0096. doi: 10.34133/bmr.0096. eCollection 2024.